Search

Displaying results 6591 - 6600 of 10000 in total
  1. Drug

    Envonalkib

    go.drugbank.com/drugs/DB21585
    Experimental

    The usage of the INN stem '-alkib' in the name indicates that Envonalkib is a ALK (anaplastic lymphoma kinase) inhibitor. Envonalkib has a monoisotopic molecular weight of 505.14 Da.

  2. Drug

    Zurletrectinib

    go.drugbank.com/drugs/DB21601
    Experimental

    The usage of the INN stem '-trectinib' in the name indicates that Zurletrectinib is a tropomyosin receptor kinase (TRK) inhibitor. Zurletrectinib has a monoisotopic molecular weight of 415.16 Da.

  3. Drug

    Rolusafine

    go.drugbank.com/drugs/DB21617
    Experimental

    The usage of the INN stem '-afine' in the name indicates that Rolusafine is a antifungal squalene mono-oxygenase inhibitor. Rolusafine has a monoisotopic molecular weight of 306.14 Da.

  4. Drug

    Merigolix

    go.drugbank.com/drugs/DB21628
    Experimental

    The usage of the INN stem '-golix' in the name indicates that Merigolix is a gonadotropin releasing hormone (GnRH) antagonist. Merigolix has a monoisotopic molecular weight of 752.24 Da.

  5. Drug

    Lerzeparib

    go.drugbank.com/drugs/DB21650
    Experimental

    The usage of the INN stem '-parib' in the name indicates that Lerzeparib is a poly-ADP-Ribose polymerase inhibitor. Lerzeparib has a monoisotopic molecular weight of 365.15 Da.

  6. Drug

    Nurandociguat

    go.drugbank.com/drugs/DB21720
    Investigational

    The usage of the INN stem '-ciguat' in the name indicates that Nurandociguat is a guanylate cyclase activator and stimulator. Nurandociguat has a monoisotopic molecular weight of 571.25 Da.

  7. Drug

    Talogreptide mesaroxetan

    go.drugbank.com/drugs/DB21743
    Experimental

    The usage of the INN stem '-xetan' in the name indicates that Talogreptide mesaroxetan is a chelating agent. Talogreptide mesaroxetan has a monoisotopic molecular weight of 1769.07 Da.

  8. Drug

    Gatipotuzumab

    go.drugbank.com/drugs/DB18861
    Investigational

    Gatipotuzumab is under investigation in clinical trial NCT01899599 (Pankomab-gex™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer).

  9. Drug

    Albuvirtide

    go.drugbank.com/drugs/DB15166
    Investigational

    Albuvirtide is under investigation in clinical trial NCT03719664 (Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects).

  10. Drug

    AZD-7295

    go.drugbank.com/drugs/DB12724
    Investigational

    AZD7295 has been investigated for the treatment of Hepatitis C.